Episode 5: Chronic Heart Failure (Chronic) – Medicine in English | MedVibe

The final common pathway of many cardiovascular diseases. Why the recent transition from "Triple Therapy" to the "Fantastic Four" is rewriting the prognosis for patients with reduced ejection fraction.In this episode of Medicine in English | MedVibe, we navigate the complex landscape of Chronic Heart Failure. We analyze the 2023/2024 ESC updates, the critical differentiation between HFrEF, HFmrEF, and HFpEF, and how to rapidly initiate disease-modifying therapies to reduce hospitalizations and mortality.Inhalt dieser Folge:Pathophysiology: Neurohumoral activation (RAAS and Sympathetic Nervous System), cardiac remodeling, and the role of natriuretic peptides (NT-proBNP).Diagnostics: Echocardiography essentials, interpreting "Heart Failure with Preserved Ejection Fraction" (HFpEF), and identifying the underlying etiology.Therapeutic Standards: The "Four Pillars" of HFrEF therapy—ARNI/ACE-i, Beta-Blockers, MRAs, and the game-changing SGLT2 Inhibitors.Advanced Care: When to consider ICD/CRT implantation and the transition to palliative or end-stage management.Target Audience: International doctors, residents in Cardiology and Internal Medicine, and healthcare professionals striving for clinical excellence in English.Patient Communication: Explaining the "Weak Pump" – using the analogy of a "tired engine" that needs the right "tune-up" (medications) to move blood efficiently and prevent fluid from backing up into the lungs.Call to Action: New episodes are released every Monday and Thursday. Subscribe now for your clinical excellence!Links & Resources:Support the channel and access exclusive supplemental materials:https://www.patreon.com/cw/MedVibeWatch us on YouTube:https://www.youtube.com/channel/UCzq0lhUMy-r8PdVKR_TFGiwListen on Spotify:FSP Klinik-Boost | MedVibe: https://open.spotify.com/show/4FO5xRBUW53CS86WD156ZG?si=zBOuC-htQmyxEJuQezGQSwMedizin auf Deutsch | MedVibe: https://open.spotify.com/show/3Ij5iBMOG1rGbTheW0Vqpy?si=U-0LKNNbQqipW-YAcX3pDwShow Notes (Keywords):Chronic Heart Failure (CHF)HFrEF vs. HFpEFSGLT2 Inhibitors (Dapagliflozin/Empagliflozin)ARNI (Sacubitril/Valsartan)NT-proBNPCardiac RemodelingMineralocorticoid Receptor Antagonists (MRA)Ejection Fraction (EF)Diuretics & Congestion ManagementCRT/ICD TherapyHashtags:#HeartFailure #Cardiology #InternalMedicine #HFrEF #HFpEF #MedicalPodcast #SGLT2i #DoctorLife #ClinicalGuidelines #MedVibe